These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35265841)

  • 21. Relationship between the Antifungal Susceptibility Profile and the Production of Virulence-Related Hydrolytic Enzymes in Brazilian Clinical Strains of
    Figueiredo-Carvalho MHG; Ramos LS; Barbedo LS; de Oliveira JCA; Dos Santos ALS; Almeida-Paes R; Zancopé-Oliveira RM
    Mediators Inflamm; 2017; 2017():8952878. PubMed ID: 28814823
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanisms of azole resistance in petite mutants of Candida glabrata.
    Brun S; Bergès T; Poupard P; Vauzelle-Moreau C; Renier G; Chabasse D; Bouchara JP
    Antimicrob Agents Chemother; 2004 May; 48(5):1788-96. PubMed ID: 15105136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vacuolar proton-translocating ATPase is required for antifungal resistance and virulence of Candida glabrata.
    Minematsu A; Miyazaki T; Shimamura S; Nishikawa H; Nakayama H; Takazono T; Saijo T; Yamamoto K; Imamura Y; Yanagihara K; Kohno S; Mukae H; Izumikawa K
    PLoS One; 2019; 14(1):e0210883. PubMed ID: 30673768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivation of sterol Delta5,6-desaturase attenuates virulence in Candida albicans.
    Chau AS; Gurnani M; Hawkinson R; Laverdiere M; Cacciapuoti A; McNicholas PM
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3646-51. PubMed ID: 16127034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum cholesterol promotes the growth of Candida glabrata in the presence of fluconazole.
    Nagi M; Tanabe K; Nakayama H; Yamagoe S; Umeyama T; Oura T; Ohno H; Kajiwara S; Miyazaki Y
    J Infect Chemother; 2013 Feb; 19(1):138-43. PubMed ID: 23233084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of Efflux Pumps and Fatty Acid Activator One Genes in Azole Resistant Candida Glabrata Isolated From Immunocompromised Patients.
    Farahyar S; Zaini F; Kordbacheh P; Rezaie S; Falahati M; Safara M; Raoofian R; Hatami K; Mohebbi M; Heidari M
    Acta Med Iran; 2016 Jul; 54(7):458-64. PubMed ID: 27424018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Candida glabrata persistence in mice does not depend on host immunosuppression and is unaffected by fungal amino acid auxotrophy.
    Jacobsen ID; Brunke S; Seider K; Schwarzmüller T; Firon A; d'Enfért C; Kuchler K; Hube B
    Infect Immun; 2010 Mar; 78(3):1066-77. PubMed ID: 20008535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
    Sanati H; Belanger P; Fratti R; Ghannoum M
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2492-6. PubMed ID: 9371355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypersusceptibility to azole antifungals in a clinical isolate of Candida glabrata with reduced aerobic growth.
    Vandeputte P; Tronchin G; Rocher F; Renier G; Bergès T; Chabasse D; Bouchara JP
    Antimicrob Agents Chemother; 2009 Jul; 53(7):3034-41. PubMed ID: 19380598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mannoprotein TIR3 (CAGL0C03872g) is required for sterol uptake in Candida glabrata.
    Inukai T; Nagi M; Morita A; Tanabe K; Aoyama T; Miyazaki Y; Bard M; Nakayama H
    Biochim Biophys Acta; 2015 Feb; 1851(2):141-51. PubMed ID: 25463012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two clinical isolates of Candida glabrata exhibiting reduced sensitivity to amphotericin B both harbor mutations in ERG2.
    Hull CM; Bader O; Parker JE; Weig M; Gross U; Warrilow AG; Kelly DE; Kelly SL
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6417-21. PubMed ID: 23027188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antifungal susceptibility profile of invasive
    Memon S; Farooqi J; Zafar U; Naqvi SF; Zafar A; Jabeen K
    J Med Microbiol; 2021 Dec; 70(12):. PubMed ID: 34878377
    [No Abstract]   [Full Text] [Related]  

  • 34. Increasing Trends of Reduced Susceptibility to Antifungal Drugs Among Clinical
    Khan Z; Ahmad S; Al-Sweih N; Mokaddas E; Al-Banwan K; Alfouzan W; Al-Obaid I; Al-Obaid K; Varghese S
    Microb Drug Resist; 2020 Aug; 26(8):982-990. PubMed ID: 32101082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discontinuation of echinocandin and azole treatments led to the disappearance of an FKS alteration but not azole resistance during clonal Candida glabrata persistent candidaemia.
    Imbert S; Castain L; Pons A; Jacob S; Meyer I; Palous M; Vezinet C; Langeron O; Hennequin C; Monsel A; Fekkar A
    Clin Microbiol Infect; 2016 Oct; 22(10):891.e5-891.e8. PubMed ID: 27484020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcription factors CgUPC2A and CgUPC2B regulate ergosterol biosynthetic genes in Candida glabrata.
    Nagi M; Nakayama H; Tanabe K; Bard M; Aoyama T; Okano M; Higashi S; Ueno K; Chibana H; Niimi M; Yamagoe S; Umeyama T; Kajiwara S; Ohno H; Miyazaki Y
    Genes Cells; 2011 Jan; 16(1):80-9. PubMed ID: 21199190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Genotyping of Vaginal Candida glabrata Isolates Using Microsatellite Marker Analysis and DNA Sequencing to Identify Mutations Associated with Antifungal Resistance].
    Döğen A; Durukan H; Güzel AB; Oksüz Z; Kaplan E; Serin MS; Serin A; Emekdaş G; Aslan G; Tezcan S; Kalkancı A; Ilkit M
    Mikrobiyol Bul; 2013 Jan; 47(1):109-21. PubMed ID: 23390908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low Level of Antifungal Resistance in Iranian Isolates of Candida glabrata Recovered from Blood Samples in a Multicenter Study from 2015 to 2018 and Potential Prognostic Values of Genotyping and Sequencing of
    Arastehfar A; Daneshnia F; Zomorodian K; Najafzadeh MJ; Khodavaisy S; Zarrinfar H; Hagen F; Zare Shahrabadi Z; Lackner M; Mirhendi H; Salehi M; Roudbary M; Pan W; Kostrzewa M; Boekhout T
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 30936110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of Azole or Echinocandin Resistance in Candida glabrata Isolates in India despite Background Prevalence of Strains with Defects in the DNA Mismatch Repair Pathway.
    Singh A; Healey KR; Yadav P; Upadhyaya G; Sachdeva N; Sarma S; Kumar A; Tarai B; Perlin DS; Chowdhary A
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610199
    [No Abstract]   [Full Text] [Related]  

  • 40. Loss of mitochondrial functions associated with azole resistance in Candida glabrata results in enhanced virulence in mice.
    Ferrari S; Sanguinetti M; De Bernardis F; Torelli R; Posteraro B; Vandeputte P; Sanglard D
    Antimicrob Agents Chemother; 2011 May; 55(5):1852-60. PubMed ID: 21321146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.